Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 36)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/AVOLC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169  View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169  View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VOLCANO CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: VOLCANO -- VOLC1$4  View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ANGO , CPHD , HTRN , ISR , NMTI , NUVA , VOLC -- MEDICAL SUPPLIES & EQUIPMENT3$4  View Abstract
3-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Volcano Corporation41$65  View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for VOLC: the economy's impact on VOLC's price and risk, featuring the powerful EconomicInvestor Star Rating6$15  View Abstract
27-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary9$25  View Abstract
27-Jan-10Roth Capital Partners, Inc.Matt DolanVOLC: Sales Guidance Comes Out Early... Looks Solid; Reiterate Buy4$104 Stars  View Abstract
Next 20

Brokerage Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
27-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary9$25  View Abstract
27-Jan-10Roth Capital Partners, Inc.Matt DolanVOLC: Sales Guidance Comes Out Early... Looks Solid; Reiterate Buy4$104 Stars  View Abstract
13-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary10$25  View Abstract
12-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary20$50  View Abstract
12-Jan-10Brean Murray & Co., Inc.Jose HarescoVOLC: Raising Estimates and Target Price Following Preannouncement4$10  View Abstract
12-Jan-10Roth Capital Partners, Inc.Matt DolanMedical Device Preannouncement Tally: Mostly Positive for 4Q09, 1H104$104 Stars  View Abstract
11-Jan-10Roth Capital Partners, Inc.Matt DolanStrong 4Q Beat on Improving Spending, Utilization & Japan; Reiterate Buy4$104 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Matt Dolan4Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update8$254 Stars  View Abstract
6-Jan-10Roth Capital Partners, Inc.Research DepartmentMorning Call Summary14$50  View Abstract

Independent Reports (Showing 1 to 10 of 27)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/AVOLC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (North America)100$169View Abstract
7-Feb-10Wright ReportsN/AWright Industry Averages: Health, Medicine and Pharmaceuticals (United States)98$169View Abstract
5-Feb-10Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VOLCANO CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.11$20View Abstract
5-Feb-10Ford Investor Services, Inc.N/AValue Graph: VOLCANO -- VOLC1$4View Abstract
5-Feb-10Ford Investor Services, Inc.N/AIndustry Value Graph: ANGO , CPHD , HTRN , ISR , NMTI , NUVA , VOLC -- MEDICAL SUPPLIES & EQUIPMENT3$4View Abstract
3-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for Volcano Corporation41$65View Abstract
2-Feb-10EconomicInvestorN/A"The Economy Matters" Report for VOLC: the economy's impact on VOLC's price and risk, featuring the powerful EconomicInvestor Star Rating6$15View Abstract
25-Jan-10Wall Street Transcript ,TheThe Wall St TranscriptANALYST INTERVIEW: Blurred Lines Between Life Sciences & Diagnostics - Stephen D. Simpson - Northland Securities, Inc.5$50View Abstract
25-Jan-10Wall Street Transcript ,TheThe Wall St TranscriptWall Street Transcript Special Report: Medical Research, Diagnostic Substances, Life Science Tools Report35$150View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.